MICHELLE TERWILLIGER: Open Payments
NPI 1912360546 · DYER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,063 in 48 payments from 21 companies in 2025. Trend: 2023 $4,068 · 2024 $3,611 · 2025 $1,063
Food & beverage: $1,063
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $172 |
| ABBVIE INC. | 11 | $145 |
| Alexion Pharmaceuticals, Inc. | 3 | $85 |
| CATALYST PHARMACEUTICALS, INC. | 3 | $84 |
| SK Life Science, Inc. | 3 | $66 |
| JAZZ PHARMACEUTICALS INC. | 2 | $56 |
| Neurelis, Inc. | 2 | $52 |
| Biogen, Inc. | 2 | $52 |
| MDD US Operations, LLC | 2 | $46 |
| Celgene Corporation | 3 | $46 |
Products named: KISUNLA, ULTOMIRIS, FYCOMPA, VYALEV, EPIDIOLEX, VALTOCO, BOTOX, Apokyn.
Industry payments across IN — which companies pay providers there.
